Aphrodisiacs pp 215-242 | Cite as

Drugs Used Clinically as Aphrodisiacs

  • P. V. Taberner


Any state of ill-health involving mental or physical discomfort is likely to have a detrimental effect on the libido. Impotence and frigidity are often merely symptoms of some underlying disorder which can be readily treated by drugs specific to that disorder. The best example of this is provided by the drugs used in the treatment of depression. The improved state of mind of the patient often coincides with the restoration of the sex drive, but it cannot really be said that the drugs taken by the patient are acting as aphrodisiacs except in a very indirect sense. The current treatment for organic, as opposed to psychogenic, impotence usually consists of hormone replacement; this has already been discussed in Chapter 6. However, until fairly recently, testosterone was sold in combination with yohimbine under the name Potensan for clinical use as an aphrodisiac. Its removal from the British National Formulary marked the end of the era of the formally recognized aphrodisiac drug in clinical medicine.


Luteinizing Hormone Sexual Function Sexual Arousal Prolactin Level Premature Ejaculation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Buffum, J. (1982) `The Effects of Drugs on Sexual Function. A Review’, J. Psychoactive Drugs 14, 5CrossRefGoogle Scholar
  2. Cooper, A.J. (1972) `Diagnosis and Management of Endocrine Impotence’, Brit. Med. J. ii, 34Google Scholar
  3. Mann, T. (1968) `Effects of Pharmacological Agents on Male Sexual Functions’, J. Reprod. Fert. Suppl. 4, 101Google Scholar
  4. 1.
    Holmberg, G. and Gershon, S. (1961) Psychopharmacologia 2, 93Google Scholar
  5. 2.
    Margolis, R. and Leslie, C.H. (1966) Curr. Ther. Res. 8, 280Google Scholar
  6. 3.
    Margolis, R. et al. (1967) Curr. Ther. Res. 9, 213Google Scholar
  7. 4.
    Miller, W.W. (1968) Curr. Ther. Res. 10, 354Google Scholar
  8. 5.
    Sobotka, J.J. (1969) Curr. Ther. Res. 11, 87Google Scholar
  9. 6.
    Cooper, A.J. et al. (1973) Irish J. Med. Sci. 142, 155CrossRefGoogle Scholar
  10. 7.
    Mortimer, C.H. et al. (1974) Brit. Med. J. iv, 617Google Scholar
  11. 8.
    Benkert, O. et al. (1975) Neuropsychobiology 1, 203CrossRefGoogle Scholar
  12. 9.
    Ambrosi, B. et al. (1977) Clin. Endocrinol. 7, 417CrossRefGoogle Scholar
  13. 10.
    Jenkins, R.B. et al. (1970) Lancet ii, 177Google Scholar
  14. 11.
    Bowers, M.B. et al. (1971) Am. J. Psychiat. 127, 1691Google Scholar
  15. 12.
    Brown. E. et al. (1978) Am. J. Psychiat. 135, 1552Google Scholar
  16. 13.
    Goodwin, F.K. et al. (1970) Lancet i, 908Google Scholar
  17. 14.
    Korten, J.J. et al. (1973) J. Am. Med. Assoc. 226, 355CrossRefGoogle Scholar
  18. 15.
    Laver, M.C. (1974) Aust. New Zeal. J. Med. 4, 29CrossRefGoogle Scholar
  19. 16.
    Alexander, W.D. and Evans, J.I. (1975) Brit. Med. J. ii,501Google Scholar
  20. 17.
    Smith, B. and Prockop, D.J. (1962) New Engl. J. Med. 267, 1338CrossRefGoogle Scholar
  21. 18.
    Oswald, I. (1966) Brit. J. Psychiat. 112, 391CrossRefGoogle Scholar
  22. 19.
    Doust, J. et al. (1972) J. Nerv. Ment. Dis. 155, 261CrossRefGoogle Scholar
  23. 20.
    Sicuteri, F. and Del Bene, E. (1975) Acta. vit. enzymol. 29, 100Google Scholar
  24. 21.
    Cremata, V.Y. (1966) Clin. Pharm. Ther. 7, 768Google Scholar
  25. 22.
    Feldman, J.M. et al. (1977) Horm. Metab. Res. 9, 156CrossRefGoogle Scholar
  26. 23.
    Benkert, O. et al. (1976) Arzneim. Forsch. 26, 1369Google Scholar
  27. 24.
    Beaumont, G. (1973) J. Int. Med. Res. 1, 469Google Scholar
  28. 25.
    Eaton, H. (1973) J. Int. Med. Res. 1, 432Google Scholar
  29. 26.
    Freed, E. (1983) Med. J. Aust. i, 551Google Scholar
  30. 27.
    Zacest, R. et al. (1983) Lancet i, 1221Google Scholar
  31. 28.
    Rubin, H.B. et al. (1979) Behay. Res. Ther. 17, 305CrossRefGoogle Scholar
  32. 29.
    Barbeau, A. (1969) Can. Med. Assoc. J. 101, 59Google Scholar

Copyright information

© Peter V. Taberner 1985

Authors and Affiliations

  • P. V. Taberner

There are no affiliations available

Personalised recommendations